Creative Planning
ONCT

Creative Planning’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Creative Planning’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,966
Closed -$21.1K – 3044
2023
Q4 		$21.1K Hold
1,966
– – ﹤0.01% 2695
2023
Q3 		$11.8K Hold
1,966
– – ﹤0.01% 2639
2023
Q2 		$13.6K Hold
1,966
– – ﹤0.01% 2528
2023
Q1 		$30.9K Hold
1,966
– – ﹤0.01% 2383
2022
Q4 		$39.3K Sell
1,966
-6
-0.3% -$119 ﹤0.01% 2255
2022
Q3 		$35K Hold
1,972
– – ﹤0.01% 2143
2022
Q2 		$44K Buy
1,972
+6
+0.3% +$134 ﹤0.01% 2070
2022
Q1 		$55K Sell
1,966
-6
-0.3% -$218 ﹤0.01% 2052
2021
Q4 		$90K Sell
1,972
-230
-10% -$15.5K ﹤0.01% 1963
2021
Q3 		$184K Buy
2,202
+1,047
+91% +$86.6K ﹤0.01% 1876
2021
Q2 		$110K Sell
1,155
-2,327
-67% -$276K ﹤0.01% 1862
2021
Q1 		$579K Sell
3,482
-2,054
-37% -$272K ﹤0.01% 1341
2020
Q4 		$543K Sell
5,536
-18,851
-77% -$1.19M ﹤0.01% 1267
2020
Q3 		$829K Hold
24,387
– – ﹤0.01% 883
2020
Q2 		$1.39M Hold
24,387
– – ﹤0.01% 630
2020
Q1 		$1.43M Buy
24,387
+515
+2% +$38.4K 0.01% 530
2019
Q4 		$1.89M Hold
23,872
– – 0.01% 533
2019
Q3 		$2.39M Buy
+23,872
New +$2.44M 0.01% 442
2018
Q4 		– Sell
-238
Closed -$52K – 2147
2018
Q3 		$52K Buy
+238
New +$571K ﹤0.01% 1873
2017
Q1 		– Sell
-3
Closed -$2K – 4968
2016
Q4 		$2K Buy
3
+2
+200% +$2.14K ﹤0.01% 4328
2016
Q3 		$1K Sell
1
-4
-80% -$3.49K ﹤0.01% 4469
2016
Q2 		$4K Buy
5
+4
+400% +$3.74K ﹤0.01% 3794
2016
Q1 		$1K Hold
1
– – ﹤0.01% 4199
2015
Q4 		$1K Hold
1
– – ﹤0.01% 4274
2015
Q3 		$1K Buy
+1
New +$1.46K ﹤0.01% 4177
2014
Q3 		– Sell
-3
Closed -$5K – 4197
2014
Q2 		$5K Buy
+3
New +$5.94K ﹤0.01% 3249

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's ONCT Position: Q1 2024 in Review

Creative Planning sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2024, closing a stake of 1,966 shares — an estimated $21.1K sold.

Creative Planning first reported a position in ONCT in Q2 2014 and held it in 26 quarters. The position peaked at $2.39M in Q3 2019. 24 funds tracked by Wall St. Rank hold ONCT as of Q1 2024.

  • Creative Planning reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Creative Planning sold 1,966 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $21.1K.
  • Creative Planning first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2014 and held it in 26 quarters.
  • Creative Planning's Oncternal Therapeutics, Inc. Common Stock position peaked at $2.39M in Q3 2019.
  • 24 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Creative Planning's 13F filing for Q1 2024, filed 13 May 2024.